AMRA Medical has been placed in the top category, \u201cOutstanding\u201d, in TIME and Statista\u2019s ranking World\u2019s Top HealthTech Companies 2026. The recognition is a step up from last year\u2019s position and highlights the company\u2019s continued development in MRI-based analysis of the body\u2019s fat and muscle distribution. <\/b><\/p>\n
For the second year in a row, the Link\u00f6ping-based company and LEAD alumnus AMRA Medical has been included on TIME and Statista\u2019s list of the world\u2019s leading HealthTech companies. In the 2026 ranking, the company is awarded the highest distinction, \u201cOutstanding\u201d, after receiving the category \u201cVery High\u201d in the first edition in 2025. <\/p>\n
\u201cThis is fantastic and a strong confirmation of AMRA\u2019s continued progress in science and technological innovation, and of the growing importance of MRI-based biomarkers in research, drug development and clinical care,\u201d says Catharina Sandberg, CEO of LEAD.<\/p>\n
AMRA Medical was founded in 2010, with roots in research at the Center for Medical Image Science and Visualization (CMIV), the Department of Biomedical Engineering, and the Department of Health, Medicine and Caring Sciences at Link\u00f6ping University.<\/p>\n
The company develops technology that uses MRI to measure and analyse how fat and muscle are distributed in the body. Through standardised biomarkers, AMRA can provide more detailed information than traditional measures of body composition. The information can, among other things, be used to study metabolic and neuromuscular health and to develop and evaluate pharmaceuticals. <\/p>\n
AMRA is also part of LEAD\u2019s history. The company was one of the incubator\u2019s most widely recognised companies in the mid-2010s. In April 2014, AMRA earned a place on Ny Teknik\u2019s prestigious 33 list, which highlights Sweden\u2019s most promising young technology companies. The following year, the company signed an agreement with the pharmaceutical company Pfizer. <\/p>\n
LiU Holding became an early shareholder in AMRA in 2011, and in 2013 the company\u2019s then CEO, Tommy Johansson, bought LiU Holding\u2019s ownership stake.<\/p>\n
\u201cAMRA’s development demonstrates the importance of what an academic-linked and cohesive innovation system can contribute over time. The company received early innovation advisory services from LiU Holding’s then Innovation Office, followed by more specific business coaching from the LEAD incubator. We also recognize the significance of Tommy Johansson as an external and highly driven entrepreneur,\u201d says Johan Lilliecreutz, CEO of LiU Holding. <\/p>\n","protected":false},"excerpt":{"rendered":"
AMRA Medical has been placed in the top category, \u201cOutstanding\u201d, in TIME and Statista\u2019s ranking World\u2019s Top HealthTech Companies 2026. The recognition is a step up from last year\u2019s position and highlights the company\u2019s continued development in MRI-based analysis of the body\u2019s fat and muscle distribution. For the second year in a row, the Link\u00f6ping-based […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[543],"tags":[],"class_list":["post-5288","post","type-post","status-publish","format-standard","hentry","category-amra-2"],"acf":[],"yoast_head":"\n